Impact2 8-Channel Electronic Pipettor, 5-250L

Products	Impact2 8-Channel Electronic Pipettor, 5-250L
Company	Matrix Technologies Corporation
Item	Impact2 8-Channel Electronic Pipettor, 5-250L
Features
Description	Ergonomic Design for Unparalleled Comfort Pick one of our pipettors up and use it. Notice the balance. Notice the trigger and ejector positionsright where they should beeven if youre left-handed. Thats because our pipettors are ergonomically designed to help avoid repetitive stress injuries caused by long hours of pipetting. Productivity In The Palm Of Your Hand Start dispensing right away or create a program with up to 40 steps. Perform neat sample additions, simple dilutions, serial dilutions, rapid reagent additions, supernatant collections or other procedures individually or programmed in sequence according to protocol. Turn the pipettor off and it automatically remembers your most recent sequence the next time you turn it on. Simple Calibration In-lab calibration can be performed quickly and easily.The software provides a trail of calibration information. Speed Control Impact and Impact2 pipettors allow convenient on-the-fly speed control. Aspiration and dispense speeds may be individually selected from three (Impact) or five (Impact2) different settings. Impact2 features two additional slower speeds for dispensing onto electrophoresis gels. Rechargeable, Long-Lasting Batteries Our multichannel pipettors come with a power supply adapter and one set of NiCad batteries rated for 1200 cycles before recharging. (16-channel pipettors are provided with lithium ion batteriessee Accessories for details.) You have the option of continuing to use the pipettor while its rechargingjust plug it into the power supply and continue operation. The battery compartment is on the underside of the control panel for convenient replacement.
Info	Matrix Technologies Corporation Customer Service: (866) 229-9770 Web site: http://www.matrixtechcorp.com/index.aspx

TAG: Impact2 Channel Electronic Pipettor

SHERIDAN SOFT-TIP® 6Fr Intubating Stylet

SHERIDAN SHER-I-SLIP® 10Fr Intubating Stylet

Satin-Slip® 10FR Intubating Stylet

SunGlide Stylette Endotracheal Tube Guide - Child

Medicine Products:

SHERIDAN SOFT-TIP® 6Fr Intubating Stylet SHERIDAN SHER-I-SLIP® 10Fr Intubating Stylet Satin-Slip® 10FR Intubating Stylet SunGlide Stylette Endotracheal Tube Guide - Child

(Date:12/3/2009)...n the life-long focus of his research and now, Pet...mprehensive Cancer Center at Georgetown University...ial-edition of Cancer Epidemiology, Biomarkers & ...actices in tobacco science from researchers the wo...nal of the American Association for Cancer Researc...

(Date:12/2/2009)...SNewswire/ -- The American Association of Poison C...ional Poison Center in Minneapolis, Minnesota as a...tone for the center. The designation by the AAPCC...58 accredited poison centers in the United States....hment. It means we have met the national standards...

(Date:12/2/2009).../ -- Reportlinker.com announces that a new market ..., Renal Disease Treatments: Products and Therapi...nal-Disease-Treatments-Products-and-Therapies.html...and services, providing data for 2008 and estimate...pound annual growth rates (CAGRs) from 2009 to 201...

(Date:12/2/2009).../ -- Reportlinker.com announces that a new market ..., Point of Care Diagnostics ,, http://www.r....html ,, Provides a complete review and analys... ,, Includes market forecasts through 2014 for ...deral regulation of POC testing ,, Analyzes ma...

(Date:12/2/2009).../ -- Reportlinker.com announces that a new market ..., Antibiotic Resistance and Antibiotic Technolog...r.com/p0166825/Antibiotic-Resistance-and-Antibioti...an in-depth review of the global market for antibi..., Offer an analysis of antibiotics resistance from...

[0] Lombardi's Shields leads special journal focused on tobacco research [1] Hennepin Regional Poison Center Designated as an Accredited Poison Control Center [1] Reportlinker Adds Renal Disease Treatments: Products and Therapies [0] Reportlinker Adds Point of Care Diagnostics [0] Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets

...t receiving the support they need to stop smoking,...ths from cardiovascular and respiratory illnesses....ffith Universitys School of Medicine, health servi...ss disorder. , He said smoking rates in people w...

...tCall/ - AlphaRx (OTC BB:ALRX -,News), an emerging...rug,delivery technology to develop novel formulati...ical development of Indaflex(TM), its topical NSAI... Cypress acquired Proprius Pharmaceuticals, Inc.,(...

... innovative,weight-loss tool is proud to announce ...rday, May 10th, in less than its first year of ope... alternative among consumers,looking for a healthy...nlike other weight-loss programs, portionpals(R) d...

...c.,(Nasdaq: MEDX ) announced today its financial ...cluding a gain of $151.8 million, or $1.19 per sha...enmab A/S stock in February 2008, Medarex,s,net in...or the same period in 2007. In addition to the gai...

...poration,(Nasdaq: MDTH ), a health care provider ...minantly the diagnosis and treatment of cardiovasc...ior Vice-President and,Treasurer and currently Int...ue to oversee and direct Treasury and,other Financ...

...an,Veterinary Medical Association (AVMA) has revis...e to provide veterinarians with additional guidanc...es. The revised policy,approved on April 12, 2008,...ation by practitioners when they work,with produce...

Other Medicine News:Health News:Quit smoking message not getting air time in mental health care 2 Health News:AlphaRx's Indaflex(TM) Continues its Clinical Development 2 Health News:Diet Industry Newcomer Hits the 1 Million Unit Mark 2 Health News:Medarex Announces 2008 First Quarter Financial Results 2 Health News:Medarex Announces 2008 First Quarter Financial Results 3 Health News:Medarex Announces 2008 First Quarter Financial Results 4 Health News:Medarex Announces 2008 First Quarter Financial Results 5 Health News:Medarex Announces 2008 First Quarter Financial Results 6 Health News:Medarex Announces 2008 First Quarter Financial Results 7 Health News:Medarex Announces 2008 First Quarter Financial Results 8 Health News:MedCath Names Parker to New Finance Post 2 Health News:Revised AVMA Policy on Castrating and Dehorning Cattle Provides Additional Guidance for Managing Pain 2

Quit smoking message not getting air time in mental health care AlphaRx's Indaflex(TM) Continues its Clinical Development Diet Industry Newcomer Hits the 1 Million Unit Mark Medarex Announces 2008 First Quarter Financial Results MedCath Names Parker to New Finance Post Revised AVMA Policy on Castrating and Dehorning Cattle Provides Additional Guidance for Managing Pain

(Date:12/3/2009)...Newswire/ -- Upsher-Smith Laboratories, Inc. today...r central nervous system (CNS) diseases with USL25...eloped program for the management of epilepsy. USL...tary formulation technology and will enter a phase...ve treatment of epilepsy patients with partial ons...

(Date:12/3/2009)...-FirstCall/ -- VirtualScopics, Inc. (Nasdaq: VSC...r clinical trials, announced today that its patent...nd Visualization" recently received issuance in Ja...ology and Product Development, Dr. Jonathan Riek, ...the uniqueness of VirtualScopics, science by joini...

(Date:12/3/2009)...lands, December 3 arGEN-X BV, a,bi...nd development of human,antibodies using its propr...ed the successful second closing of its Series A e...ional EUR 3.0 million (~USD 4.5 million),from two ...ivate Equity and,VIB (the prestigious Flemish rese...

Breaking Medicine Technology:Upsher-Smith Announces Milestone in Development of CNS Strategy 2 VirtualScopics Receives Issuance in Japan of Prominent Patent 2 VirtualScopics Receives Issuance in Japan of Prominent Patent 3 arGEN-X Concludes EUR 12.5 Million Series A Financing Round 2 arGEN-X Concludes EUR 12.5 Million Series A Financing Round 3 arGEN-X Concludes EUR 12.5 Million Series A Financing Round 4 Stretching Test May Reveal Arterial Stiffness 59206 1 Stretching Test May Reveal Arterial Stiffness 59206 2 Smart For Life 28TM 29 Makes Debut on BJs com 59203 1 Smart For Life 28TM 29 Makes Debut on BJs com 59203 2 Smart For Life 28TM 29 Makes Debut on BJs com 59203 3 Genomic Health Announces Data Confirming Manual Microdissection of Biopsy Cavities Is Essential for Accurate Recurrence Risk Assessment in Early Stage 59200 1 Genomic Health Announces Data Confirming Manual Microdissection of Biopsy Cavities Is Essential for Accurate Recurrence Risk Assessment in Early Stage 59200 2 Genomic Health Announces Data Confirming Manual Microdissection of Biopsy Cavities Is Essential for Accurate Recurrence Risk Assessment in Early Stage 59200 3 Genomic Health Announces Data Confirming Manual Microdissection of Biopsy Cavities Is Essential for Accurate Recurrence Risk Assessment in Early Stage 59200 4 Genomic Health Announces Data Confirming Manual Microdissection of Biopsy Cavities Is Essential for Accurate Recurrence Risk Assessment in Early Stage 59200 5

[0] Upsher-Smith Announces Milestone in Development of CNS Strategy [0] VirtualScopics Receives Issuance in Japan of Prominent Patent [0] arGEN-X Concludes EUR 12.5 Million Series A Financing Round